About Careers MedBlog Contact us

Skin Cancer Drug - Keytruda, Boosts Immune System to Fight Lung Cancer

by Julia Samuel on April 20, 2015 at 5:44 PM
Font : A-A+

Skin Cancer Drug - Keytruda, Boosts Immune System to Fight Lung Cancer

Keytruda, the recently US approved drug shows early promise for some patients with advanced lung cancer though it is approved for advanced melanoma. The drug boosts the cancer-fighting potential and the body's immune system.

Keytruda (pembrolizumab) belongs to a new group of drugs that blocks a pathway called PD-1, which then frees up the immune system to attack cancer cells approved another PD-1 drug nivolumab (Opdivo) for treating some cases of advanced lung cancer.


The U.S. National Cancer Institute estimates that only about one-third of patients see any tumor shrinkage with standard chemotherapy, and even with treatment, people typically survive for a year.

The Merck-funded study involved 495 patients in the advanced stages of non-small-cell lung cancer, and infused Keytruda every two to three weeks. Dr. Edward Garon, an associate professor of medicine at the University of California, Los Angeles and his team analyzed their tumor samples to measure levels of a protein called PD-L1 and correlate with their likelihood of responding to the treatment.

The tumors for nearly 19% patients shrunk by 30% but among patients with PD-L1 activity, 45% responded to the drug. Although Keytruda is on the market, it is not specifically approved for lung cancer yet.

Source: Medindia


Recommended Reading

Latest Drug News

Are Painkillers Safe for Back Pain?
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
 India's First Urinary Incontinence Drug Launched
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
 New Ray of Hope for Atrial Fibrillation Patients With Kidney Disease
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.
Anti-viral Drug Bulevirtide Helps Treat Chronic Hepatitis D
Patients with hepatitis D virus-related chronic advanced liver disease are treated with an antiviral therapy.
Antiviral Drug Paxlovid Linked to Lower Risk of Hospital Admission
Among people with COVID-19, Paxlovid drug was found to reduce hospitalization and death risk by 90%, revealed study.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

Skin Cancer Drug - Keytruda, Boosts Immune System to Fight Lung Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests